secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fortress Biotech, Inc. (FBIO)
CIK:        0001429260
Form:       8-K
Filed at:   2022-12-19T23:59:59+00:00
Accession:  0001558370-22-018778
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fortress Biotech Appoints Lucy Lu, M.D. to Board of Directors
-------------------------------------------------------------

- Lucy Lu, M.D. appointed to Fortress Biotech Board effective December 14, 2022.
- Dr. Lu previously served as Fortress CFO (2012-2017) and CEO of subsidiary Avenue Therapeutics.
- She brings over 20 years of biotech finance and drug development experience including roles at Citigroup.
- Standard-form indemnification agreement entered with Dr. Lu, consistent with other directors' terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1429260/000155837022018778/0001558370-22-018778-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1429260/000155837022018778/fbio-20221214x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-018778

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer